Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Hyperintensity of integrin‐targeted fluorescence agent IntegriSense750 accurately predicts flap necrosis compared to Indocyanine green

Head & Neck(2021)10.1002/hed.26914Source: DataRank Database

Hyperintensity of integrin‐targeted fluorescence agent IntegriSense750 accurately predicts flap necrosis compared to Indocyanine green is a research paper published in Head & Neck (2021). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 0.20)OA: greenTopics (39)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Alyssa K. Ovaitt,Jason C. Fleming ORCID,Anna G. Sorace ORCID,Patrick N. Song ORCID,Ameer Mansur ORCID

Live enrichment

PubMed:34697855 PMC:PMC8688316 OpenAlex:https://openalex.org/W3209699041

American Cancer Society

Grant: RSG‐18‐006‐01‐CCE

National Institutes of Health

Grant: NIH NCI 1R37CA245157‐01A1

National Institutes of Health

Grant: NCI R R01CA240589

NCI NIH HHS

Grant: P30 CA013148

NCI NIH HHS

Grant: R37 CA245157

NCI NIH HHS

Grant: R01 CA240589

NCI NIH HHS

Grant: R21 CA292196

National Institutes of Health

Grant: 1R37CA245157-01A1

Reduction of Tumor-Positive Margins in Oncology Surgery

National Institutes of Health

Grant: 5R01CA240589-04

Personalizing immunotherapy in HER2+ breast cancer through quantitative imaging

FWCI

0.20

Citation Percentile

0.5%

Citation Trend

2024

greenLicense: Wiley Online Library User Agreement

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8688316

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/hed.26914

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/hed.26914

journalhttps://doi.org/10.1002/hed.26914

Fields of Study

Reconstructive Surgery and Microvascular TechniquesNanoplatforms for cancer theranosticsInfectious Aortic and Vascular Conditions03 medical and health sciences0302 clinical medicineAnimalsColoring AgentsFluorescenceIndocyanine GreenIntegrinsMiceNecrosisSurgical Flaps

MeSH Terms

AnimalsColoring AgentsFluorescenceIndocyanine GreenNecrosisSurgical FlapsIntegrinsMice

Keywords

Indocyanine greenNecrosisMedicineTumor necrosis factor alphaNuclear medicineSurgeryPathologyInternal medicineFlap NecrosisAxial Pattern FlapIntegrisense750Murine Flap ModelIntegrinsMiceAnimalsColoring AgentsFluorescenceSurgical Flaps

Sustainable Development Goals

SDG 3: 3. Good health